Pain in the genital, pubic and pelvic area
Frequent urination
Pain during urination
Weak or an interrupted urine stream
Pain during ejaculation
Dark and smelly urine
Nickel, J. C., Downey, J., Hunter, D., & Clark, J. (2001). PREVALENCE OF PROSTATITIS-LIKE SYMPTOMS IN A POPULATION BASED STUDY USING THE NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX.
The Journal of Urology, 165(3), 842–845. doi:10.1016/s0022-5347(05)66541-x
ACUTE BACTERİAL PROSTATİTİS
Click for Details
CHRONIC BACTERIAL PROSTATITIS
Click for Details
CHRONIC PROSTATITİS / CHRONIC PELVIC PAIN SYNDROME
Click for Details
ASYMPTOMAIC INFLAMMATORY PROSTATITIS
Click for Details
Domingue, G. J., & Hellstrom, W. J. G. (1998). Prostatitis. Clinical Microbiology Reviews, 11(4), 604–613. doi:10.1128/cmr.11.4.604
It is suitable for combined use with different treatment options.
Its efficacy has been clinically proven.
Suspension form provides easy absorption.
It provides ease of use for people who have difficulty in swallowing capsules.
It provides fast and effective support in the treatment of prostatitis with its multi-component technology consisting of 5 different ingredients approved by EMA.
It has standardized contents. The amount of active ingredient in each dose is determined.
It is suitable for long-term use. It does not cause antibiotic resistance.
Copyright © 2022 Setonda®. All rights reserved unless otherwise stated. All trademarks are owned by or licensed for use by Setonda and its affiliates.